Methods of using death receptor ligands and CD20 antibodies

Details for Australian Patent Application No. 2005282440 (hide)

Owner Genentech, Inc.

Inventors Ashkenazi, Avi J.

Agent Griffith Hack

Pub. Number AU-A-2005282440

PCT Pub. Number WO2006/029224

Priority 60/607,909 08.09.04 US; 60/666,553 30.03.05 US

Filing date 7 September 2005

Wipo publication date 16 March 2006

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/02 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

8 March 2007 PCT application entered the National Phase

  PCT publication WO2006/029224 Priority application(s): WO2006/029224

5 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005282441-Connector port for network interface device

2005282437-Anti-tumor compounds with angeloyl groups